文献速递呼吸道感染

口腔护理预防非呼吸机医院获得性肺炎的有效性(HAPPEN):澳大利亚多中心阶梯楔形整群随机试验

Effectiveness of oral care for the prevention of non-ventilator hospital-acquired pneumonia (HAPPEN): a multicentre, stepped-wedge, cluster-randomised trial in Australia
RSS 订阅 · PubMed 高证据 · 肺炎 · 2026-06-08

HAPPEN试验在澳大利亚3家医院9个病房开展开放队列阶梯楔形整群随机试验,纳入住院≥48小时的8870例患者进行分析。强化口腔护理干预使非呼吸机医院获得性肺炎(NV-HAP)累积风险比为0.40(95%CI 0.19-0.82),感染率从每100住院风险日1.00降至0.41。

要点

  • 强化口腔护理干预使NV-HAP累积风险比为0.40(95%CI 0.19-0.82)。
  • NV-HAP发生率由对照条件46/4523(1.0%)降至干预条件32/4347(0.7%)。
  • 口腔护理方案完成比例由474/2988(15.9%)升至1727/2791(61.9%)。

核心结论

  • 这项多中心随机对照试验表明,与常规护理相比,改善口腔护理可降低住院患者NV-HAP发生率。
  • 作者认为该发现为未来预防指南和医院感染控制政策提供了新颖且具有临床意义的证据。

研究设计与样本

  • HAPPEN试验为开放队列、阶梯楔形、整群随机试验,在澳大利亚3家医院开展。
  • 采用简单随机化将9个病房(集群)分配到3个治疗序列。
  • 纳入18岁及以上入住试验集群的患者,结局评估限于住院至少48小时者。
  • 干预包括三部分:强化口腔护理实施与产品提供、患者与员工教育、审计与反馈,由专职研究护士实施。
  • 对照为常规实践,即由医务人员按医院政策进行口腔护理。

主要发现

  • 共有12446例住院患者符合接受干预条件,其中3336例因入住试验集群不足48小时被排除,8870例纳入分析。
  • 4523例暴露于对照条件,4347例暴露于干预条件。
  • 8870例中78例(0.9%)确诊NV-HAP:对照条件46/4523(1.0%),干预条件32/4347(0.7%)。
  • 干预暴露与NV-HAP累积风险比0.40(95%CI 0.19-0.82)相关,感染率从每100住院风险日1.00降至0.41。
  • 干预暴露下呼吸道或上呼吸道感染的累积风险比为1.64(95%CI 0.61-4.39),口腔感染为1.08(95%CI 0.66-1.77)。

关键数值与推荐

  • NV-HAP按欧洲疾病预防与控制中心标准定义。
  • 次要结局包括医院获得性下呼吸道感染、上呼吸道感染和口腔感染,采用既定定义并通过病历审查确定。

临床怎么用

  • 作者认为改善口腔护理可降低住院患者NV-HAP发生率,该证据可用于指导未来预防指南和医院感染控制政策。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「局限性」,故未列出该栏;全文请点「阅读原文」。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Lancet Infect Dis. 2026 Oct;26(10):1022-1030. doi: 10.1016/S1473-3099(26)00235-5. Epub 2026 Jun 8. ABSTRACT BACKGROUND: Non-ventilator hospital-acquired pneumonia (NV-HAP) is among the most prevalent health-care-associated infections, yet remains under-reported, understudied, and infrequently targeted by infection prevention strategies. Oral care is considered a key preventive measure; however, there are few high-quality randomised controlled trials conducted in hospital settings. The aim of this study is to evaluate whether an enhanced oral care intervention reduces the incidence of NV-HAP. METHODS: The Hospital Acquired Pneumonia Prevention (HAPPEN) trial was an open-cohort, stepped-wedge, cluster-randomised trial conducted across three Australian hospitals. Large public or private hospitals were eligible. Simple randomisation was used to allocate nine wards (clusters) across three treatment sequences. All patients aged 18 years or older admitted to a trial cluster were eligible, with outcomes assessed for patients admitted for at least 48 h. The intervention comprised three components: enhanced delivery of oral care and provision of products, patient and staff education, and audit and feedback, delivered by dedicated research nurses. The control was usual practice-ie, oral care performed by health-care workers as per hospital policy. Primary and secondary outcomes were analysed in the intention-to-treat population. The primary outcome was NV-HAP incidence, defined according to European Centre for Disease Prevention and Control criteria. Secondary outcomes included hospital-acquired lower and upper respiratory tract infections and oral cavity infections. Outcomes were defined using established definitions and determined following a review of medical records. This study was single blinded, with data collectors masked to allocated treatment sequences. The completed trial is registered with the Australia New Zealand Clinical Trials Registry (ACTRN12624000187549). FINDINGS: The trial was conducted from June 3, 2024, to Aug 22, 2025. A total of 12 446 admitted patients were eligible to receive the intervention, 3336 of whom were excluded because they were admitted to a trial cluster for less than 48 h. A total of 8870 patients were analysed, with 4523 exposed to the control condition and 4347 exposed to the intervention condition. NV-HAP was confirmed in 78 (0·9%) of 8870 patients: 46 (1·0%) of 4523 under the control condition and 32 (0·7%) of 4347 under the intervention condition. Intervention exposure was associated with a cumulative hazard ratio of 0·40 (95% CI 0·19-0·82), representing a decrease from 1·00 to 0·41 infections per 100 admission-days at risk. Intervention exposure resulted in a cumulative hazard ratio of 1·64 (95% CI 0·61-4·39) for lower or upper respiratory tract infection, and 1·08 (0·66-1·77) for oral cavity infection. The proportion of participants who completed the oral care protocol increased from 474 (15·9%) of 2988 to 1727 (61·9%) of 2791 following intervention exposure. Interpretation This multicentre randomised controlled trial demonstrates that improving oral care reduces NV-HAP incidence among hospitalised patients, compared with usual care. Our findings provide novel and clinically important evidence to inform future prevention guidelines and hospital infection control policy. Funding Medical Research Future Fund.

来源:PubMed 高证据 · 肺炎,查看原文。版权归原作者所有。

引用

  1. PubMed 高证据 · 肺炎:Effectiveness of oral care for the prevention of non-ventilator hospital-acquired pneumonia (HAPPEN): a multicentre, stepped-wedge, cluster-randomised trial in Australia

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。